{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-001352","form_type":"8-K","ticker":"ISCO","cik":"0001355790","company_name":"International Stem Cell CORP","filed_at":"2022-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.093712+00:00","generated_at":"2026-06-27T17:52:09.042836+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"International Stem Cell issues $2.9M promissory note to CEO Andrey Semechkin for working capital","bullets":["Unsecured, non-convertible note for $2,900,000 issued to CEO/Co-Chairman on Jan 13, 2022.","Replaces prior $2,650,000 note plus additional $250,000 provided by Dr. Semechkin.","Interest rate of 4.5% per annum; principal and accrued interest due March 15, 2022.","Borrower may prepay without penalty at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-001352","json":"https://secwatch.observer/filing/0001564590-22-001352.json","markdown":"https://secwatch.observer/filing/0001564590-22-001352.md","text":"https://secwatch.observer/filing/0001564590-22-001352.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1355790/000156459022001352/0001564590-22-001352-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1355790/000156459022001352/isco-8k_20220113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T17:52:09.042836+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}